DOI:
10.1055/s-00034913
Phlebologie
LinksClose Window
References
Turpie AG, Lensing AW, Fuji T, Boyle DA.
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients.
Blood Coagul Fibrinolysis 2009;
20: 114-121.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.